News

Zacks.com on MSN6d
Schrodinger (SDGR) Moves 27.4% Higher: Will This Strength Last?
Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...
American Association of Individual Investors3d
Why Acrivon Therapeutics, Inc.’s (ACRV) Stock Is Down 11.25%
Acrivon Therapeutics, Inc.’s ACRV share price has dipped by 11.25%, which has investors questioning if this is right time to ...
pharmaphorum5d
David Hung’s Nuvation Bio seals merger with blank cheque firm Panacea
The first of these, CDK 2/4/6 inhibitor NUV-422 ... There are also drugs targeting BET, WEE1 and A2A in preclinical development for leukaemia and solid tumours, and a series of PARP-targeting ...
GP magazine2d
ACE inhibitors and renal artery stenosis
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...